Net profit of Novartis India rose 18.67% to Rs 24.22 crore in the quarter ended September 2025 as against Rs 20.41 crore during the previous quarter ended September 2024. Sales rose 3.71% to Rs 90.33 crore in the quarter ended September 2025 as against Rs 87.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales90.3387.10 4 OPM %26.4420.62 - PBDT33.1728.14 18 PBT32.6527.56 18 NP24.2220.41 19 Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 28 October 2025.Powered by Capital Market - Live News

Net profit of Novartis India rose 7.30% to Rs 27.62 crore in the quarter ended June 2025 as against Rs 25.74 crore during the previous quarter ended June 2024. Sales declined 5.14% to Rs 87.55 crore in the quarter ended June 2025 as against Rs 92.29 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales87.5592.29 -5 OPM %31.1125.97 - PBDT37.7534.23 10 PBT37.2233.68 11 NP27.6225.74 7 Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 29 July 2025.Powered by Capital Market - Live News

Novartis India announced that the 77th Annual General Meeting(AGM) of the company will be held on 31 July 2025.Powered by Capital Market - Live News